RogerS.KeresztesMD

Oncology • Stony Brook, NY

Assistant Professor, Medicine, Stony Brook University SOM

Join to view full profile

Dr. Keresztes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Keresztes' full profile

Already have an account?

Office
3 Edmund Pellegrino Rd
Stony Brook, NY 11794
Phone+1 631-638-1000

Fax+1 631-444-7530

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1990 - 1993
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1987 - 1990
Rutgers New Jersey Medical SchoolClass of 1987

Certifications & Licensure

NY State Medical License 1989 - 2025

Clinical Trials

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer Start of enrollment: 2004 Apr 01
Terminated
Phase 1, Phase 2
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Completed
Phase 2
Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung Start of enrollment: 2016 Apr 10
Terminated
Phase 1, Phase 2
Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy Start of enrollment: 2019 Jun 27
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Unilateral conjunctival Classic Kaposi Sarcoma following a COVID 19 booster.
Emily White, Nicholas Fazio, Konstantinos Tourmouzis, Samuel Ryu, Paul T Finger
American Journal of Ophthalmology Case Reports. 2024-06-01
6 citations
Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504).
Saad A. Khan, Z. Sun, Suzanne E. Dahlberg, Jyoti Malhotra, Roger Keresztes
JTO Clinical and Research Reports. 2021-05-01
2 citations
Risk Stratification of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy: An Institutional Analysis.
Amna Falak Sher, Sowmini Medavaram, Barbara Nemesure, Sean Clouston, Roger Keresztes
Cancer Management and Research. 2020-08-11

Press Mentions

Multidisciplinary Care Leads to Higher Survival Rates for Lung Cancer PatientsDecember 14th, 2018

Other Languages

Hungarian